NRGN and Alzheimer disease: Samples of patients with AD pathology (AD group) could be separated from those without signs of AD pathology, including other dementias (non-AD group), with an area under the curve (AUC) of 0.85 for neurogranin and 0.66 for YKL-40 (Fig. 4).